Cargando…

Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B

Corpus callosum abnormalities are common brain malformations with a wide clinical spectrum ranging from severe intellectual disability to normal cognitive function. The etiology is expected to be genetic in as much as 30–50% of the cases, but the underlying genetic cause remains unknown in the major...

Descripción completa

Detalles Bibliográficos
Autores principales: Halgren, C, Kjaergaard, S, Bak, M, Hansen, C, El-Schich, Z, Anderson, CM, Henriksen, KF, Hjalgrim, H, Kirchhoff, M, Bijlsma, EK, Nielsen, M, den Hollander, NS, Ruivenkamp, CAL, Isidor, B, Le Caignec, C, Zannolli, R, Mucciolo, M, Renieri, A, Mari, F, Anderlid, B-M, Andrieux, J, Dieux, A, Tommerup, N, Bache, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464360/
https://www.ncbi.nlm.nih.gov/pubmed/21801163
http://dx.doi.org/10.1111/j.1399-0004.2011.01755.x
_version_ 1782245416117469184
author Halgren, C
Kjaergaard, S
Bak, M
Hansen, C
El-Schich, Z
Anderson, CM
Henriksen, KF
Hjalgrim, H
Kirchhoff, M
Bijlsma, EK
Nielsen, M
den Hollander, NS
Ruivenkamp, CAL
Isidor, B
Le Caignec, C
Zannolli, R
Mucciolo, M
Renieri, A
Mari, F
Anderlid, B-M
Andrieux, J
Dieux, A
Tommerup, N
Bache, I
author_facet Halgren, C
Kjaergaard, S
Bak, M
Hansen, C
El-Schich, Z
Anderson, CM
Henriksen, KF
Hjalgrim, H
Kirchhoff, M
Bijlsma, EK
Nielsen, M
den Hollander, NS
Ruivenkamp, CAL
Isidor, B
Le Caignec, C
Zannolli, R
Mucciolo, M
Renieri, A
Mari, F
Anderlid, B-M
Andrieux, J
Dieux, A
Tommerup, N
Bache, I
author_sort Halgren, C
collection PubMed
description Corpus callosum abnormalities are common brain malformations with a wide clinical spectrum ranging from severe intellectual disability to normal cognitive function. The etiology is expected to be genetic in as much as 30–50% of the cases, but the underlying genetic cause remains unknown in the majority of cases. By next-generation mate-pair sequencing we mapped the chromosomal breakpoints of a patient with a de novo balanced translocation, t(1;6)(p31;q25), agenesis of corpus callosum (CC), intellectual disability, severe speech impairment, and autism. The chromosome 6 breakpoint truncated ARID1B which was also truncated in a recently published translocation patient with a similar phenotype. Quantitative polymerase chain reaction (Q-PCR) data showed that a primer set proximal to the translocation showed increased expression of ARID1B, whereas primer sets spanning or distal to the translocation showed decreased expression in the patient relative to a non-related control set. Phenotype–genotype comparison of the translocation patient to seven unpublished patients with various sized deletions encompassing ARID1B confirms that haploinsufficiency of ARID1B is associated with CC abnormalities, intellectual disability, severe speech impairment, and autism. Our findings emphasize that ARID1B is important in human brain development and function in general, and in the development of CC and in speech development in particular.
format Online
Article
Text
id pubmed-3464360
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-34643602012-10-05 Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B Halgren, C Kjaergaard, S Bak, M Hansen, C El-Schich, Z Anderson, CM Henriksen, KF Hjalgrim, H Kirchhoff, M Bijlsma, EK Nielsen, M den Hollander, NS Ruivenkamp, CAL Isidor, B Le Caignec, C Zannolli, R Mucciolo, M Renieri, A Mari, F Anderlid, B-M Andrieux, J Dieux, A Tommerup, N Bache, I Clin Genet Short Reports Corpus callosum abnormalities are common brain malformations with a wide clinical spectrum ranging from severe intellectual disability to normal cognitive function. The etiology is expected to be genetic in as much as 30–50% of the cases, but the underlying genetic cause remains unknown in the majority of cases. By next-generation mate-pair sequencing we mapped the chromosomal breakpoints of a patient with a de novo balanced translocation, t(1;6)(p31;q25), agenesis of corpus callosum (CC), intellectual disability, severe speech impairment, and autism. The chromosome 6 breakpoint truncated ARID1B which was also truncated in a recently published translocation patient with a similar phenotype. Quantitative polymerase chain reaction (Q-PCR) data showed that a primer set proximal to the translocation showed increased expression of ARID1B, whereas primer sets spanning or distal to the translocation showed decreased expression in the patient relative to a non-related control set. Phenotype–genotype comparison of the translocation patient to seven unpublished patients with various sized deletions encompassing ARID1B confirms that haploinsufficiency of ARID1B is associated with CC abnormalities, intellectual disability, severe speech impairment, and autism. Our findings emphasize that ARID1B is important in human brain development and function in general, and in the development of CC and in speech development in particular. Blackwell Publishing Ltd 2012-09 /pmc/articles/PMC3464360/ /pubmed/21801163 http://dx.doi.org/10.1111/j.1399-0004.2011.01755.x Text en © 2011 John Wiley & Sons A/S http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Short Reports
Halgren, C
Kjaergaard, S
Bak, M
Hansen, C
El-Schich, Z
Anderson, CM
Henriksen, KF
Hjalgrim, H
Kirchhoff, M
Bijlsma, EK
Nielsen, M
den Hollander, NS
Ruivenkamp, CAL
Isidor, B
Le Caignec, C
Zannolli, R
Mucciolo, M
Renieri, A
Mari, F
Anderlid, B-M
Andrieux, J
Dieux, A
Tommerup, N
Bache, I
Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B
title Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B
title_full Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B
title_fullStr Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B
title_full_unstemmed Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B
title_short Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B
title_sort corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of arid1b
topic Short Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464360/
https://www.ncbi.nlm.nih.gov/pubmed/21801163
http://dx.doi.org/10.1111/j.1399-0004.2011.01755.x
work_keys_str_mv AT halgrenc corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT kjaergaards corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT bakm corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT hansenc corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT elschichz corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT andersoncm corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT henriksenkf corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT hjalgrimh corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT kirchhoffm corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT bijlsmaek corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT nielsenm corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT denhollanderns corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT ruivenkampcal corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT isidorb corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT lecaignecc corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT zannollir corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT mucciolom corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT renieria corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT marif corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT anderlidbm corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT andrieuxj corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT dieuxa corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT tommerupn corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b
AT bachei corpuscallosumabnormalitiesintellectualdisabilityspeechimpairmentandautisminpatientswithhaploinsufficiencyofarid1b